STAA STAAR Surgical Company
Healthcare$33.34+2.68%ClosedMarket Cap: $1.66B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.60
P/S
5.57
EV/EBITDA
102.87
DCF Value
$1.39
FCF Yield
-3.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.4%
Operating Margin
-1.7%
Net Margin
-7.2%
ROE
-6.1%
ROA
-4.7%
ROIC
-1.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $93.5M | 72.2% | $17.4M | $5.2M | $— | — |
| Q4 null | $57.8M | 75.7% | $-10.9M | $-18.3M | $— | — |
| FY null | $239.4M | 76.2% | $-45.9M | $-80.4M | $— | — |
| Q3 null | $94.7M | 82.2% | $18.5M | $8.9M | $— | — |
| Q2 null | $44.3M | 74.0% | $-30.0M | $-16.8M | $— | — |
| Q1 null | $42.6M | 65.8% | $-57.4M | $-54.2M | $— | — |
| Q4 null | $49.0M | 64.7% | $-27.9M | $-34.2M | $— | — |
| FY null | $313.9M | 76.3% | $-12.6M | $-20.2M | $— | — |
| Q3 null | $88.6M | 77.3% | $5.7M | $10.0M | $— | — |
| Q2 null | $99.0M | 79.2% | $11.9M | $7.4M | $— | — |
| Q1 null | $77.4M | 78.9% | $-2.3M | $-3.3M | $— | — |
| Q4 2023 | $76.3M | 79.6% | $10.4M | $7.8M | $0.16 | — |